【正文】
[1] 中華醫(yī)學會肝病學分會, 感染病學分會1 慢性乙型肝炎防治指南[J ] . 肝臟, 2005 , 10 (4) : 3482357.[ 2 ] Liaw YF,Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease, (15):15211531 [3 ] 賈繼東. 進一步重視肝硬化臨床診治工作的系統(tǒng)性和規(guī)范性[J ] .中華肝臟病雜志,2005 ,13 (6) :401 402 .[ 4 ] Dienstag JL , Goldin RD , Heat hcote EJ , et al . Histological out e during long2term lamivudine t herapy [J ] . Gast roenterology ,2003 ,124 :105 117.[ 5 ] Liaw YF , Sung JJ , Chow wc , et al . Lamivudine for patient s wit h chronic hepatitis B and advanced liver disease[J ] . N Engl J Med ,2004 ,351 :1521 1531. [6]駱抗先. 乙型肝炎活動性肝硬化: 從肝組織學討論一些臨床問題[J ] . 肝臟,2007 ,12 (1) :54 55. [7] 萬謨彬. 核苷(酸) 類似物治療慢性乙型肝炎的藥物選擇[J ] . 病毒性肝炎論壇,2006 ,4 (2) :6 8.[8] Marcellin P ,Chang TT,Lim SG, et al . Adefovir dipivoxil for the treatment of hepatitis B e antigen2positive chronic hepatitis B. N Engl J Med ,2003 ,348∶808~816[9]Stephanos J , Hadziyannis GV , Papat heodoridis. Treatment of HBeAg2negative chronic hepatitis B wit h new drugs(adefovi